Status:
COMPLETED
rTMS in Treatment of Obsessive Compulsive Disorder (OCD)
Lead Sponsor:
Queen's University
Collaborating Sponsors:
Military Medical Academy, Bulgaria
Dokuz Eylul University
Conditions:
Obsessive Compulsive Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Low frequency (1Hz) rTMS applied bilaterally and simultaneously over SMA for 6 weeks in addition to the standard treatment regimen for OCD, will lead to significant improvement in patients' symptoms. ...
Eligibility Criteria
Inclusion
- signed patient informed consent;
- primary obsessive compulsive disorder;
- YBOCS score at least 20;
- males/females 18-65yrs;
- treated with adequate dose of SSRI at least 8 weeks at some stage of illness;
- currently using adequate, stable dose of SSRI at least 4 weeks but not responding.
Exclusion
- schizophrenia, other psychotic disorders, bipolar I, current major depressive disorder (HDRS(17)\>18, substance/alcohol dependence within last 6 months;
- severe axis II;
- suicidal score\>=6 on MINI;
- metallic implant in cranium;
- severe/unstable medical conditions;
- not responding to ECT or had TMS in last 6 months;
- history epilepsy;
- neurological disorder leading to increased intracranial pressure;
- severe cardiac disorder/intracardiac lines, pacemakers;
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00616486
Start Date
January 1 2008
End Date
November 1 2012
Last Update
December 16 2015
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Military Medical Academy
Sofia, Bulgaria
2
Providence Care, Mental Health Services
Kingston, Ontario, Canada, K7L 4X3
3
Dokuz Eylul University
Izmir, Turkey (Türkiye)